Join our panel of experts on Thursday 17th November, to discuss the challenges and opportunities for the biotech and pharmaceutical industries and the transformational changes that are now becoming possible. Our ability to develop, manufacture and distribute therapeutics has changed dramatically with covid, Brexit and the increasingly volatile geopolitical landscape. That has created numerous challenges for life sciences companies in the risks they face, in securing supply chains and in managing regulatory affairs. But periods of great change bring opportunities too as new products and approaches emerge and markets evolve. |
